晚期卵巢癌患者治疗全程中睡眠障碍与疲乏的体验与感知:一项质性研究
该研究对20例Ⅲ期和Ⅳ期卵巢癌患者进行半结构化个体访谈,其中17/20正在接受治疗。患者报告高水平的睡眠障碍和疲乏,干扰认知、社交和身体功能,且症状性质随治疗轨迹变化。多数患者以化疗为基准评估症状负担,对医护人员沟通和症状管理建议不满意。
要点
- 晚期卵巢癌患者普遍报告高水平睡眠障碍和疲乏,干扰认知、社交和身体功能。
- 多数患者(16/20)以化疗为基准评估当前症状负担,症状在化疗输注后立即最重,维持治疗期间较轻但更持续。
- 患者对医护人员缺乏沟通和症状管理建议感到不满,提示需改进筛查和分级干预。
核心结论
- 晚期卵巢癌患者睡眠障碍和疲乏强度高,且在不同治疗阶段的主观体验性质不同;患者对医护人员沟通的不满提示需改进筛查和分级干预。
研究设计与样本
- 质性研究,对20例确诊并在三年内接受治疗的Ⅲ期和Ⅳ期卵巢癌患者进行个体半结构化访谈,其中17/20正在接受治疗。
主要发现
- 参与者报告高水平睡眠障碍和疲乏,干扰认知、社交和身体功能。
- 睡眠和疲乏问题的性质随治疗轨迹变化;多数参与者(16/20)以化疗为基准评估当前症状负担。
- 疲乏和睡眠障碍被描述为更强烈且呈周期性,化疗输注后立即症状负担最高,治疗间期周期性改善;维持治疗期间症状强度较低但更持续。
- 参与者采用多种策略管理症状,但20例中13例疲乏持续存在。
- 参与者对医护人员缺乏沟通和症状管理建议感到不满。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Sleep disturbance and fatigue are prevalent among patients with advanced ovarian cancer (OC) and associated with poor health-related quality of life (HRQoL). This study aimed to illustrate the lived experiences of OC patients with sleep disturbance and fatigue and the range of factors that they perceive as contributing to these symptoms. METHODS: Individual semi-structured interviews were conducted with twenty patients with Stage III and IV OC diagnosed and treated within three years (17/20 receiving treatment). Interview transcripts were analyzed based on emergent themes in the data and study goals. RESULTS: Participants reported high levels of sleep disturbance and fatigue, which interfered with their cognitive, social, and physical function. The nature of their sleep and fatigue issues varied across the treatment trajectory. The majority (16/20) used chemotherapy as a benchmark to assess their current symptom burden. Fatigue and sleep disturbance were described as more intense and cyclic, with the highest symptom burden immediately following chemotherapy infusions followed by periodic improvement between treatments, whereas symptoms were less intense, but more persistent during maintenance therapy. Participants pursued a variety of strategies to manage symptoms, but fatigue persisted among thirteen of twenty participants. Participants were dissatisfied with providers' lack of communication and recommendations to manage symptoms. CONCLUSION: Findings underscore that while sleep disturbance and fatigue are intense among participants with OC, the lived experiences of these symptoms are qualitatively distinct at different points during treatment. Participants' dissatisfaction with providers' communication suggests the need for improved screening and scaled interventions for advanced OC patients.
引用
- Newell A, Andac-Jones E, Gonzalo M, et al. Patients with advanced ovarian cancer and their experiences and perceptions of sleep disturbance and fatigue across the treatment trajectory: A qualitative study. Gynecol Oncol. 2025. PMID: 40411968. doi:10.1016/j.ygyno.2025.05.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。